Trump Drug Tariff Order: 100% Duties Shake Pharma Stocks
SOOJZ PROJECT Trump order enables 100% tariffs on high-cost patented drugs. Pharma sector reels as the White House leverages massive duties to force pricing agreements and expansion of the TrumpRx.gov platform . Trump Drug Tariff Order news shows notable movement today as the administration targets the pharmaceutical industry with unprecedented protectionist measures. Traders are noticing a sharp decline in the healthcare sector following the signing of an executive order that enables tariffs of up to 100% on specific patented medications. This aggressive policy is designed to force pharmaceutical companies into pricing agreements with the administration, with the threat of massive duties serving as the primary lever for negotiation. Understanding these patterns is essential to act quickly and confidently, as this "tariff-for-pricing" model introduces a new level of political risk to one of the S&P 500's most stable sectors At S&P 500 Insights T...